Literature DB >> 32410038

Staining and Quantification of β-Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.

Amy Christensen1, Christian J Pike2.   

Abstract

Studies of Alzheimer's disease (AD) using experimental systems most often involve transgenic mouse models that are characterized by neural accumulation of β-amyloid protein (Aβ), which is widely hypothesized to have a key role in AD pathogenesis. Quantification of Aβ in transgenic mice typically is accomplished through both biochemical and histochemical approaches. In this chapter, we describe two techniques for the histological detection of Aβ, immunostaining with Aβ antibodies and staining with the amyloid dye thioflavin S, and its quantification using digital imaging.

Entities:  

Keywords:  Immunohistochemistry; Quantitative imaging; Thioflavin S; Transgenic mice; β-Amyloid

Mesh:

Substances:

Year:  2020        PMID: 32410038      PMCID: PMC7299244          DOI: 10.1007/978-1-0716-0592-9_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Optimization of techniques for the maximal detection and quantification of Alzheimer's-related neuropathology with digital imaging.

Authors:  Brian J Cummings; Amy J L Mason; Ronald C Kim; Philip C-Y Sheu; Aileen J Anderson
Journal:  Neurobiol Aging       Date:  2002 Mar-Apr       Impact factor: 4.673

Review 2.  Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics.

Authors:  Carlo Sala Frigerio; Bart De Strooper
Journal:  Annu Rev Neurosci       Date:  2016-04-04       Impact factor: 12.449

Review 3.  Emerging concepts in Alzheimer's disease.

Authors:  Harry V Vinters
Journal:  Annu Rev Pathol       Date:  2014-10-29       Impact factor: 23.472

4.  Aβ measurement by enzyme-linked immunosorbent assay.

Authors:  Stephen D Schmidt; Matthew J Mazzella; Ralph A Nixon; Paul M Mathews
Journal:  Methods Mol Biol       Date:  2012

Review 5.  Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.

Authors:  George S Bloom
Journal:  JAMA Neurol       Date:  2014-04       Impact factor: 18.302

Review 6.  The amyloid hypothesis of Alzheimer's disease at 25 years.

Authors:  Dennis J Selkoe; John Hardy
Journal:  EMBO Mol Med       Date:  2016-06-01       Impact factor: 12.137

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.